Dr Reddy's Laboratories Ltd
NSE:DRREDDY

Watchlist Manager
Dr Reddy's Laboratories Ltd Logo
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Watchlist
Price: 1 226.7 INR -1.53% Market Closed
Market Cap: 1T INR
Have any thoughts about
Dr Reddy's Laboratories Ltd?
Write Note

Dr Reddy's Laboratories Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dr Reddy's Laboratories Ltd
Revenue Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
M
MANKIND

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Revenue
â‚ą289.5B
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Revenue
â‚ą265.1B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
10%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Revenue
â‚ą503.1B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
8%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Revenue
â‚ą206.2B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
10%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Revenue
â‚ą112.2B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
9%
M
Mankind Pharma Ltd
NSE:MANKIND
Revenue
â‚ą103.3B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Dr Reddy's Laboratories Ltd's Revenue?
Revenue
289.5B INR

Based on the financial report for Jun 30, 2024, Dr Reddy's Laboratories Ltd's Revenue amounts to 289.5B INR.

What is Dr Reddy's Laboratories Ltd's Revenue growth rate?
Revenue CAGR 5Y
13%

Over the last year, the Revenue growth was 11%. The average annual Revenue growth rates for Dr Reddy's Laboratories Ltd have been 14% over the past three years , 13% over the past five years .

Back to Top